TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.

Shaveta Vinayak, Melinda L. Telli, Lee S. Schwartzberg et al.|Journal of Clinical Oncology|2018

Cited by 77